Novartis AG News

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

16:30 ET

SC TO-T/A: Third party tender offer statement (Amendment)

Aug 7 22:22 ET

SC TO-T/A: Third party tender offer statement (Amendment)

Aug 2 16:36 ET

SC TO-T/A: Third party tender offer statement (Amendment)

Aug 1 16:32 ET

SC TO-T/A: Third party tender offer statement (Amendment)

Jul 31 16:34 ET

SC TO-T/A: Third party tender offer statement (Amendment)

Jul 30 16:36 ET

SC TO-T/A: Third party tender offer statement (Amendment)

Jul 29 16:37 ET

SC TO-T/A: Third party tender offer statement (Amendment)

Jul 25 16:35 ET

SC TO-T/A: Third party tender offer statement (Amendment)

Jul 18 16:32 ET

6-K: Novartis Second Quarter and Half Year 2024 Condensed Interim Financial Report – Supplementary Data

Jul 18 06:11 ET

SC TO-T/A: Third party tender offer statement (Amendment)

Jul 11 16:35 ET

SC TO-T: Third party tender offer statement

Jul 5 06:06 ET

SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Novartis BidCo Germany AG(91.17%),Novartis BidCo AG(91.17%), etc.

Jun 21 16:34 ET

SC TO-C: Written communication relating to an issuer or third party tender offer

Jun 20 15:42 ET

SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Novartis BidCo AG(91.17%),Novartis Pharma AG(91.17%), etc.

Jun 17 16:37 ET

SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Novartis BidCo AG(89.47%),Novartis Pharma AG(89.47%), etc.

Jun 10 16:37 ET

SC TO-T/A: Third party tender offer statement (Amendment)

Jun 4 16:36 ET

SD: Specialized disclosure report

May 31 06:09 ET

SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Novartis BidCo AG(79.58%),Novartis Pharma AG(79.58%), etc.

May 28 16:44 ET

SC TO-T/A: Third party tender offer statement (Amendment)

May 24 16:36 ET